Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibody
Biotech
New cancer cases prompt Kyowa to shutter rocatinlimab trials
Kyowa had originally planned to seek FDA approval of the asset in atopic dermatitis in the first half of this year.
Gabrielle Masson
Mar 3, 2026 11:00am
Roche pens $1B deal for respiratory bispecific from China
Oct 30, 2025 5:04am
Ipsen inks €1B buyout of French biotech ImCheck
Oct 22, 2025 10:33am
Novartis scores double phase 3 win in Sjögren's syndrome
Aug 11, 2025 4:33am
Kaken strengthens late-stage HAE portfolio with $32M Astria deal
Aug 6, 2025 10:21am
Novartis' ianalumab fails to show promise in dermatology study
Jul 17, 2025 4:28am
